Skip to Content

Provera

In the US, Provera (medroxyprogesterone systemic) is a member of the following drug classes: contraceptives, hormones/antineoplastics, progestins and is used to treat Abnormal Uterine Bleeding, Amenorrhea, Birth Control, Endometrial Cancer, Endometrial Hyperplasia - Prophylaxis, Endometriosis and Renal Cell Carcinoma.

US matches:

UK matches:

Ingredient matches for Provera

Medroxyprogesterone

Medroxyprogesterone is reported as an ingredient of Provera in the following countries:

  • Egypt
  • Latvia
  • Lebanon
  • Peru
  • United States

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Provera in the following countries:

  • Australia
  • Belgium
  • Brazil
  • Canada
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Estonia
  • Finland
  • Hong Kong
  • Hungary
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Lithuania
  • Malta
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • South Africa
  • South Korea
  • Sweden
  • Taiwan
  • United Kingdom

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide